Rationale, design, and protocol for a hybrid type 1 effectiveness-implementation trial of a proactive smoking cessation electronic visit for scalable delivery via primary care: the E-STOP trial

• Published in: BMC family practice Vol. 24; no. 1; p. 254
• Main Authors: Fahey, Margaret C, Wahlquist, Amy E, Diaz, Vanessa A, Player, Marty S, Natale, Noelle, Sterba, Katherine R, Chen, Brian K, Hermes, Eric D A, Carpenter, Mathew J, Dahne, Jennifer
• Format: Journal Article
• Language: English
• Published: England BioMed Central 29-11-2023; BMC
• Subjects: Abstinence; Adult; Automation; Cigarette Smoking; Cigarettes; Clinics; Counseling; Electronic health records; Electronic visit (e-visit); Humans; Medical screening; Nicotiana; Patients; Primary care; Primary Health Care; Randomized Controlled Trials as Topic; Smoking cessation; Smoking Cessation - methods; Study Protocol; Text messaging; United States; Web portals; United States; United States > US; South Carolina; Smoking cessation; Electronic visit (e-visit); Electronic health records; Primary care
• ISSN: 2731-4553; 2731-4553; 1471-2296
• DOI: 10.1186/s12875-023-02205-3

Cigarette smoking remains the leading cause of preventable disease and death in the United States. Primary care offers an ideal setting to reach adults who smoke cigarettes and improve uptake of evidence-based cessation treatment. Although U.S. Preventive Services Task Force Guidelines recommend the 5As model (Ask, Advise, Assess, Assist, Arrange) in primary care, there are many barriers to its implementation. Automated, comprehensive, and proactive tools are needed to overcome barriers. Our team developed and preliminarily evaluated a proactive electronic visit (e-visit) delivered via the Electronic Health Record patient portal to facilitate evidence-based smoking cessation treatment uptake in primary care, with promising initial feasibility and efficacy. This paper describes the rationale, design, and protocol for an ongoing Hybrid Type I effectiveness-implementation trial that will simultaneously assess effectiveness of the e-visit intervention for smoking cessation as well as implementation potential across diverse primary care settings.
The primary aim of this remote five-year study is to examine the effectiveness of the e-visit intervention vs. treatment as usual (TAU) for smoking cessation via a clinic-randomized clinical trial. Adults who smoke cigarettes are recruited across 18 primary care clinics. Clinics are stratified based on their number of primary care providers and randomized 2:1 to either e-visit or TAU. An initial baseline e-visit gathers information about patient smoking history and motivation to quit, and a clinical decision support algorithm determines the best evidence-based cessation treatment to prescribe. E-visit recommendations are evaluated by a patient's own provider, and a one-month follow-up e-visit assesses cessation progress. Main outcomes include: (1) cessation treatment utilization (medication, psychosocial cessation counseling), (2) reduction in cigarettes per day, and (3) biochemically verified 7-day point prevalence abstinence (PPA) at six-months. We hypothesize that patients randomized to the e-visit condition will have better cessation outcomes (vs. TAU). A secondary aim evaluates e-visit implementation potential at patient, provider, and organizational levels using a mixed-methods approach. Implementation outcomes include acceptability, adoption, fidelity, implementation cost, penetration, and sustainability.
This asynchronous, proactive e-visit intervention could provide substantial benefits for patients, providers, and primary care practices and has potential to widely improve reach of evidence-based cessation treatment.
NCT05493254.